Agenda

07:00 – 09:00 Breakfast
Session I
08:50 – 09:00 Welcoming Remarks
09:00 – 10:30

ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASES

At the end of this session, participants will be better able to:

  • Recognize a variety of complex rheumatological entities and manage them.
  • Identify, understand and discuss the nature and results of recent research work done by their peers.
10:30 – 11:00 Break
Session II
11:00 – 12:00

Maladie de Sjögren : de la pathophysiologie au traitement.

Xavier Mariette, MD, PhD

At the end of this session, participants will be better able to:

  • Understand the pathophysiologic mechanisms of Sjögren’s disease.
  • Know the most often used drugs in its treatment.
  • Discover new therapeutic pathways.
12:00 – 13:00 Lunch
Session III
13:00 – 13:30

Grossesses lupiques

Évelyne Vinet, MD, PhD

At the end of this session, participants will be better able to:

  • Discuss the general principles of pregnancy planning in women with SLE.
  • Choose rheumatologic drugs compatible with pregnancy and lactation.
  • Revise the American College of Rheumatology guidelines on management of reproductive health in patients with SLE.
Session IV
15:00 – 14:30

La place de l’arthroplastie dans le traitement des pathologies dégénératives de l’épaule.

Stéphane Pelet, MD, PhD, FRCSC

At the end of this session, participants will be better able to:

  • Recognize the indications for the various types of arthroplasties and refer the right patients at the right time for surgical management.
  • Describe to their patients the potential benefits of reverse total shoulder arthroplasty.
  • Set up appropriate therapeutic measures while awaiting surgical treatment.
16:00 – 17:00 Poster Session
19:00

Dinner & Awards
07:00 – 09:00 Breakfast
Session V
9:00 – 9:30

L’histoire de la déplétion des lymphocytes B dans les maladies auto-immunes : du rituximab aux CAR-T cells.


Xavier Mariette, MD, PhD

À la fin de cette session, les participants sauront mieux :

  • Understand the different roles of B lymphocytes in the pathogenesis of auto-immune diseases.
  • Know the currently used means to deplete B lymphocytes in auto-immune diseases.
  • Discover the effects of bispecific Ab and of CAR-T cells to deplete B lymphocytes in auto-immune diseases.
10:30 – 11:00 Break
Session VI
11:00 – 12:00

Brosser les dents et passer la soie dentaire: pourquoi la santé buccale est pertinente en rhumatologie


Carol Hitchon, MD, FRCPC, MSC

À la fin de cette session, les participants sauront mieux :

  • Review the association between oral health and autoimmune rheumatic diseases.
  • Describe oral mucosal immunology and potential relevance to rheumatoid arthritis (RA).
12:00 Closing Remarks